Are Muthoot Microfin Ltd latest results good or bad?

1 hour ago
share
Share Via
Muthoot Microfin Ltd's Q4 FY26 results show a strong operational recovery with record net sales of ₹631.81 crores and a net profit of ₹71.12 crores, a significant turnaround from the previous year’s loss. However, challenges remain with a low return on equity and high debt levels.
Muthoot Microfin Ltd's latest financial results for Q4 FY26 indicate a notable operational recovery following a challenging FY25. The company reported net sales of ₹631.81 crores, reflecting a sequential growth of 4.81% and a year-on-year increase of 13.83%. This marks the highest quarterly revenue in the company's recent history, showcasing a significant turnaround from the previous year's struggles with asset quality.
The net profit for the quarter stood at ₹71.12 crores, which is a 13.90% increase compared to the prior quarter. This is a stark contrast to the substantial loss of ₹401.15 crores reported in Q4 FY25, highlighting the effectiveness of the company's recovery strategies. The operating margin reached a record 52.56%, indicating improved cost management and operational efficiency. The interest coverage ratio also improved to 1.43 times, reflecting the company's enhanced capability to service its debt. Despite these positive operational metrics, the company continues to face challenges, particularly with a return on equity (ROE) of 6.98%, which remains below industry standards. The high debt-to-equity ratio of 3.20 indicates significant leverage, amplifying both potential returns and risks associated with the business. Additionally, Muthoot Microfin's valuation has seen an adjustment in its evaluation, reflecting the market's perception of the company's financial health and future prospects. The substantial increase in foreign institutional investor (FII) holdings to 22.82% suggests growing confidence in the company's recovery narrative, although the overall institutional presence remains limited. In summary, Muthoot Microfin Ltd's Q4 FY26 results demonstrate a strong operational recovery, marked by record revenues and improved profitability metrics, while also highlighting ongoing concerns regarding valuation and financial leverage.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News